Concise Review: Boosting T‐Cell Reconstitution Following Allogeneic Transplantation—Current Concepts and Future Perspectives

Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a large number of malignant and nonmalignant (inherited) diseases of the hematopoietic system. Nevertheless, non‐HLA identical transplantations are complicated by a severe T‐cell immunodeficiency associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Simons, Laura, Cavazzana, Marina, André, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Enabling Technologies for Cell‐Based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591542/
https://www.ncbi.nlm.nih.gov/pubmed/30887712
http://dx.doi.org/10.1002/sctm.18-0248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591542/
https://www.ncbi.nlm.nih.gov/pubmed/30887712
http://dx.doi.org/10.1002/sctm.18-0248

Ejemplares similares